Fig. 5From: The tyrosine kinase inhibitor nilotinib is more efficient than mitotane in decreasing cell viability in spheroids prepared from adrenocortical carcinoma cellsCell viability analysis of H295R cell line treated with sunitinib (Sun) alone or with mitotane (Mit). MTS assay in monolayer cells after Sun treatment for 3 days (a) and (b) a combination of Sun and 10 μM Mit for 72 h; (c) MTS assay in spheroids after treatment with Sun or a combination of Sun and Mit; (d) phase-contrast photomicrography of spheroids after 72 h of treatment; (e) confocal microscopy images of spheroids after 72 h of treatment (100 μm). The results are expressed as the mean ± SEM; ANOVA *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001; n = 3–4Back to article page